Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02670785 · ClinicalTrials.gov registry record · Phase 2
A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy
A Phase 2 study of Menopause and Dyspareunia, sponsored by Warner Chilcott.
- Completed
- Registry status
- Phase 2
- Development phase
- 203
- Enrollment target
- 20
- Study locations
NCT02670785: Completed Phase 2 study of Menopause and Dyspareunia, sponsored by Warner Chilcott.
NCT02670785 is a Phase 2 study of Menopause and Dyspareunia that has completed, run by Warner Chilcott. The registered enrollment target is 203 participants, below the 9,390-participant average among 54 other Menopause trials with a reported enrollment target (98% lower). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02670785, a Phase 2 study of Menopause and Dyspareunia, has completed, sponsored by Warner Chilcott.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 203 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study will access the safety and efficacy of three doses of estradiol vaginal capsules in postmenopausal women with vulvovaginal atrophy.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Estradiol Vaginal Capsule (EVC)
Study Locations (20)
Florida
- Women's Medical Research Group, LLC - Clearwater
- Radiant Research, Inc. - Pinellas Park
- Comprehensive Clinical Trials, LLC - West Palm Beach
North Carolina
- Carolina Women's Research and Wellness Center - Durham
- Hawthorne Medical Research, Inc. - Winston-Salem
Ohio
- Rapid Medical Research, Inc. - Cleveland
- Women's Health Research - Columbus
Texas
- Radiant Research, Inc. - Dallas
- Radiant Research, Inc. - San Antonio
Washington
- Seattle Women's Health, Research, Gynecology - Seattle
- North Spokane Women's Clinic - Spokane
Arizona
- Visions Clinical Research-Tucson - Tucson
California
- Genesis Center for Clinical Research - San Diego
Connecticut
- Coastal Connecticut Research, LLC - New London
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2016-02-15 |
| Est. Completion | 2016-11-14 |
| Phase | Phase 2 |
What the finished NCT02670785 record still lists
NCT02670785 is an interventional study that assigns participants to a tested intervention. The registered 203 participants enrollment target is mid-sized for trials with a published cap, below the 9,390-participant average among 54 other Menopause trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Menopause appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02670785 names 20 study sites across 14 states, led by Florida, North Carolina, Ohio.
Frequently Asked Questions
What is clinical trial NCT02670785 about?
NCT02670785 is a clinical study titled "A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy". This study will access the safety and efficacy of three doses of estradiol vaginal capsules in postmenopausal women with vulvovaginal atrophy.
What is the current status of trial NCT02670785?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 203 participants. The study started on 2016-02-15. Estimated completion is 2016-11-14.
What conditions does trial NCT02670785 study?
This clinical trial studies the following conditions: Menopause, Dyspareunia, Vulvovaginal Atrophy.
What interventions are being tested in trial NCT02670785?
The interventions under investigation include: Placebo (DRUG), Estradiol Vaginal Capsule (EVC) (DRUG).
Who is sponsoring clinical trial NCT02670785?
This trial is sponsored by Warner Chilcott, which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02670785 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menopause
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02670785's enrollment target sits among peer trials
203 8th of 54 higher than 47 of 54 other Menopause trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Menopause trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Anabolic Effect of Testosterone on Pelvic Floor Muscles
RECRUITING · Phase 2
-
Effects of Hemp-Derived Cannabinoids on Menopause Symptoms
RECRUITING · Phase 2
-
Impact of Cannabinoids on Menopause Symptoms
RECRUITING · Phase 2
-
PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition
ACTIVE NOT RECRUITING · Phase 2
-
Hormone Replacement in Menopausal Women With Epilepsy
COMPLETED · Phase 2
-
Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05652686 · 203 participants · Phase 1
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- NCT06063122 · 203 participants · NA
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
- NCT07031245 · 203 participants · NA
Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI